Alcohol Consumption Common in Adults With Cancer Diagnosis
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 10, 2023 -- Alcohol consumption and risky drinking behaviors are common among cancer survivors, according to a study published online Aug. 10 in JAMA Network Open.
Mengyao Shi, M.B.B.S., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues characterized alcohol consumption patterns among U.S. cancer survivors. Data were included for 15,199 participants who reported a cancer diagnosis and for 1,839 patients receiving treatment.
The researchers found that 77.7 percent of cancer survivors were current drinkers, including 13.0, 23.8, and 38.3 percent who exceeded moderate drinking, reported binge drinking, and engaged in hazardous drinking, respectively. Survivors who were younger than 65 years, men, those of Hispanic ethnicity, those who received a diagnosis before age 18 years, and ever smokers were more likely to exceed moderate drinking (odds ratios: 2.90 for age younger than 50 years, 1.84 for age 50 to 64 years, 2.38 for men, 1.31 for Hispanic ethnicity, 1.52 for age younger than 18 years at diagnosis, 2.46 for former smokers, and 4.14 for current smokers) or binge drinking (odds ratios: 4.46, 2.15, 2.10, 1.31, 1.71, 1.69, and 2.27, respectively) after multivariable adjustment. The likelihood of being hazardous drinkers was increased for those diagnosed before age 18 years and for former and current smokers (odds ratios: 1.52, 1.83, and 2.13, respectively). Of those survivors receiving treatment, 76.4 percent were current smokers, including 12.1, 23.4, and 38.4 percent who exceeded moderate drinking, reported binge drinking, and engaged in hazardous drinking, respectively.
"Given the short- and long-term adverse treatment and oncologic outcomes associated with alcohol consumption, additional research and implementation studies are critical to address this emerging concern among cancer survivors," the authors write.
Two authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
Living Outside of Comprehensive Cancer Center Catchment Area Tied to Later-Stage Diagnosis
TUESDAY, May 28, 2024 -- Disadvantaged populations and those living outside of a comprehensive cancer center's main catchment area have higher odds of receiving a diagnosis of...
Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals
TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.